Compare DV & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DV | TWST |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 3.0B |
| IPO Year | 2021 | 2018 |
| Metric | DV | TWST |
|---|---|---|
| Price | $9.80 | $49.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 8 |
| Target Price | $16.18 | ★ $45.75 |
| AVG Volume (30 Days) | ★ 2.8M | 970.6K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $748,291,000.00 | $376,572,000.00 |
| Revenue This Year | $12.68 | $18.91 |
| Revenue Next Year | $9.75 | $15.07 |
| P/E Ratio | $31.65 | ★ N/A |
| Revenue Growth | 13.92 | ★ 20.32 |
| 52 Week Low | $7.61 | $23.30 |
| 52 Week High | $16.82 | $57.88 |
| Indicator | DV | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 57.26 |
| Support Level | $8.95 | $41.65 |
| Resistance Level | $11.60 | $57.88 |
| Average True Range (ATR) | 0.34 | 2.82 |
| MACD | -0.06 | 0.28 |
| Stochastic Oscillator | 49.29 | 86.48 |
DoubleVerify Holdings Inc is a media effectiveness platform that leverages artificial intelligence (AI) to drive superior outcomes for international brands by creating transparent ad transactions. Its solutions provide unbiased data analytics to improve the effectiveness, quality and return on advertising investments. DV Authentic Ad is its proprietary metric measuring whether an ad was delivered in a brand suitable environment, fully viewable, by a real person and in geography, while DV Pinnacle delivers these metrics in real time. The Company's solutions are integrated across programmatic platforms, social media channels and digital publishers, and are accredited by the Media Rating Council for digital ad measurement. It operates in the United States and international markets.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.